Medication info
Gatidine 20 mg (Famotidine)

Gatidine 20 mg (Famotidine)

Prescription medicationTabletOral
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
Light green, round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202002369 · Approved 2020.04.04 · Insurance code 649507980

Summary

Main use
Improvement of lesions associated with acid-related disorders (ulcers, gastroesophageal reflux disease, etc.), upper gastrointestinal bleeding, and gastritis
Who takes it
Adults
Adult dose
1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (caused by peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Famotidine 20 mg orally twice daily (after breakfast and dinner, or at bedtime), or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Famotidine 10 mg orally twice daily (after breakfast and dinner, or at bedtime), or 20 mg orally once daily (at bedtime). Adjust the dose appropriately according to age and symptoms.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of lesions associated with acid-related disorders (ulcers, gastroesophageal reflux disease, etc.), upper gastrointestinal bleeding, and gastritis

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
View approved original text

This medication is effective for digestive-related diseases such as gastric and duodenal ulcers and anastomotic ulcers. It is also helpful in treating upper gastrointestinal bleeding due to acute stress ulcers or hemorrhagic gastritis. It is used for conditions such as gastroesophageal reflux disease and Zollinger-Ellison syndrome, and contributes to the improvement of gastric mucosal lesions such as erosion, bleeding, redness, and swelling. It is also effective during acute exacerbations of acute gastritis or chronic gastritis. This medication alleviates the symptoms of these gastrointestinal diseases and aids recovery, improving treatment outcomes.

How to take

Adult dose

1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (caused by peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Famotidine 20 mg orally twice daily (after breakfast and dinner, or at bedtime), or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Famotidine 10 mg orally twice daily (after breakfast and dinner, or at bedtime), or 20 mg orally once daily (at bedtime). Adjust the dose appropriately according to age and symptoms.

Precautions

This medication should not be used by individuals who have had an allergic reaction to this medication or similar types of drugs. Additionally, this medication contains lactose, so individuals with a genetic issue that prevents lactose digestion should avoid taking it. Particular caution should be exercised when using this medication in individuals with a history of drug allergies, impaired kidney function, heart disease, liver dysfunction, and the elderly. In cases of reduced kidney function, the concentration of the medication may increase, requiring a decrease in dosage or an increase in dosing intervals. Individuals with heart disease may be at risk of side effects affecting the heart, necessitating caution. This medication may cause rare but serious side effects such as severe allergic reactions, blood-related disorders, serious abnormalities in the skin and mucous membranes, liver dysfunction, muscle damage, cardiac rhythm disturbances, consciousness disturbances, nephritis, and pneumonia; if any abnormal signs appear, discontinue use immediately and consult a doctor. Common side effects may include skin rash, decrease in blood cell count, digestive issues, blood pressure changes, respiratory issues, liver function abnormalities, neurological symptoms, endocrine abnormalities, and joint pain. The medication should be used at the minimum necessary dose while observing its effectiveness carefully, and if no effect is observed, alternative treatments should be considered. The medication dissolves in the mouth but is not absorbed sublingually, so it should be swallowed with water or saliva. Patients undergoing hemodialysis should be cautious when using this medication with specific phosphate binders as the effectiveness of the phosphate binders may be reduced. This medication may alter the drug concentration or effect when taken with certain antifungal agents or some chemotherapeutic drugs, so consultation with a doctor or pharmacist is essential. Elderly patients may be more likely to have impaired kidney function, potentially leading to prolonged retention of the drug in the body, thus necessitating dosage adjustment. Pregnant women or women who may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as safety during pregnancy has not been fully confirmed. This medication can also be passed through breast milk, so it is advisable to discontinue breastfeeding while using this medication. Safety in children has not been fully confirmed, so caution is advised when using this medication in this population. Finally, this medication may obscure the symptoms of gastric cancer, so it should only be used after it has been confirmed that the condition is not gastric cancer.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized flushing
  • vascular edema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 87 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Lyell's syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzyme levels
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized convulsions
  • tonic convulsions
  • clonic convulsions
  • interstitial nephritis
  • acute renal failure
  • fever
  • rash
  • abnormal renal function test results
  • interstitial pneumonia
  • high fever
  • cough
  • dyspnea
  • abnormal chest X-ray findings
  • hypocontractility
  • rash
  • urticaria
  • erythema
  • facial edema
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • loose stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • agitation
  • excitement
  • decreased libido
  • sensory abnormalities
  • heaviness
  • reversible confusional state
  • depression
  • dizziness
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is room temperature between 1°C and 30°C, and it is advisable to avoid extremely hot or cold places.

Appearance and packaging

Appearance

Light green, round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.